Primary record
D-threo-PPMP, 1R,2R-(+)-1-phenyl-2-palmitoylamino-3-N-morpholine-1-propanol, powder
- 库存
- 5,069 克
- 纯度
- 98.2 %
- CAS
- 149022-18-4
化合物标识与属性
- CAS
- 149022-18-4
- PubChem CID
- 3008318
- SMILES
- CCCCCCCCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@@H](C2=CC=CC=C2)O
- Canonical SMILES
- CCCCCCCCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c1ccccc1
名称与同义词
- D-threo-PPMP
- PPMP
- DL-threo-PPMP
- (1R,threo)-PPMP
- DL-PPMP
- 149022-18-4
- AC1MHO1F
- (R,R)-PPMP
- CBiol_001749
- BSPBio_001296
- KBioGR_000016
- KBioSS_000016
- (1R,2R)-PPMP
- orb1691747
- orb2664584
- SCHEMBL5452846
- CHEMBL1522805
- BCBcMAP01_000004
- CHEBI:75126
- KBio2_000016
- KBio2_002584
- KBio2_005152
- KBio3_000031
- KBio3_000032
- DTXSID00164156
- Bio1_000035
- Bio1_000524
- Bio1_001013
- Bio2_000016
- Bio2_000496
- HMS1791A18
- HMS1989A18
- HMS3402A18
- ( inverted exclamation markA)-PPMP
- ZINC33359848
- AKOS040756730
- CID3008318
- HY-116535B
- HY-116535C
- (1R,2R)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
- IDI1_033766
- NCGC00161370-01
- NCGC00161370-02
- NCGC00161370-03
- BP-42317
- DA-63045
- J641.739F
- CS-0255236
- N-[(1R,2R)-1-hydroxy-3-morpholin-4-yl-1-phenylpropan-2-yl]hexadecanamide
- DL-threo-1-Phenyl-2-palmitoylamino-3-morpholino-1-propanol
- Hexadecanamide, N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-, rel-
- 139889-53-5
- N-[(1R,2R)-1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide
- Q27145141
- D,L-THREO-1-PHENYL-2-HEXADECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL
- Hexadecanamide, N-((1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl)-
- (1R,2R)-3-morpholino-2-palmitoylamino-1-phenylpropan-1-ol
- (R,R)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
- D-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
- (1R,2R)-2-hexadecanoylamino-3-morpholino-1-phenylpropan-1-ol
- (1R,threo)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
- 1R,2R-(+)-1-phenyl-2-palmitoylamino-3-N-morpholine-1-propanol
- DL-threo-1-Phenyl-2-palmitoylamino-3-morpholino-1-propanol, 98%
- Hexadecanoic acid ((1R,2R)-2-hydroxy-1-morpholin-4-ylmethyl-2-phenyl-ethyl)-amide
- rel-N-[(1R,2R)-2-Hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-hexadecanamide
- 6-Methyl-3-(beta-D-2-deoxy-ribofuranosyl)furano[2,3-d]pyrimidin-2-one
- D,L-THREO-1-PHENYL-2-HEXADECANOYLAMINO-3-MORPHOLINO-1-PROPANOLHCL
- N-[(1R,2R)-1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]palmitamide
- N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]hexadecanamide
- N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]palmitamide
- N-[(1R,2R)-2-hydroxy-1-(morpholinomethyl)-2-phenyl-ethyl]hexadecanamide
- N-[[(1R,2R)-1-Phenyl-1-hydroxy-3-morpholinopropane]-2-yl]hexadecanamide
- D-threo-PPMP, 1R,2R-(+)-1-phenyl-2-palmitoylamino-3-N-morpholine-1-propanol, powder
- Hexadecanamide, N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2- phenylethyl]-
- rel-N-[(1R,2R)-2-Hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]hexadecanamide